LONDON--(BUSINESS WIRE)--Technavio’s latest report on the global angina pectoris drugs market provides an analysis on the most important trends expected to impact the market outlook from 2017-2021.

LONDON, Feb. 21, 2018 /PRNewswire/ -- Download the full report: https://www.reportbuyer.com/product/5291766 The global angina pectoris drugs market is expected to be ...

LONDON, Oct. 3, 2017 /PRNewswire/ -- According to Stratistics MRC, the Global Angina Pectoris Drugs Market is accounted for $8501.3 million in 2016 and expected to grow at a CAGR of 6.7% to reach ...

DURING the past two years, interest in the use of vitamin E in the treatment of various forms of heart disease has been aroused by several reports of its efficacy appearing in medical and nonmedical ...

The goals of treatment are to decrease the frequency of angina, increase longevity, and improve patients' QOL. Management of risk factors is an essential component of this therapy. Also important is ...

This was an investigator-initiated, prospective, open-label, randomized, controlled study conducted at Hiroshima University Hospital between April 2011 and March 2013. We studied 30 patients with ...

Individuals with undetected stable angina pectoris (SAP) as a consequence of undiagnosed coronary artery disease are at high risk of poor quality of life and a premature fatal event (for example, ...